{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:33:11Z","timestamp":1793403191936,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.psychres.2025.116622","type":"journal-article","created":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T02:45:40Z","timestamp":1751683540000},"page":"116622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Efficacy and Safety of LSD in the treatment of mental and substance use disorders: A systematic review of randomized controlled trials"],"prefix":"10.1016","volume":"351","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6402-6806","authenticated-orcid":false,"given":"Maria Helha","family":"Fernandes-Nascimento","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5409-8272","authenticated-orcid":false,"given":"Priscila","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8133-6723","authenticated-orcid":false,"given":"Andr\u00e9 Brooking","family":"Negr\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2025.116622_bib0011","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1176\/appi.psychotherapy.1966.20.3.415","article-title":"The use of LSD in psychotherapy and alcoholism","volume":"20","author":"Abramson","year":"1967","journal-title":"Am. J. PsychOther"},{"key":"10.1016\/j.psychres.2025.116622_bib0001","unstructured":"Agency for Healthcare Research and Quality (AHRQ), 2023. Methods Guide for Effectiveness and Comparative Effectiveness Reviews [WWW Document]. URL https:\/\/effectivehealthcare.ahrq.gov\/products\/collections\/cer-methods-guide."},{"key":"10.1016\/j.psychres.2025.116622_bib35","series-title":"Introduction to meta-analysis","author":"Borenstein","year":"2021"},{"key":"10.1016\/j.psychres.2025.116622_bib0002","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00005053-197002000-00003","article-title":"Lysergic acid diethylamide as a variable in the hospital treatment of alcoholism","volume":"150","author":"Bowen","year":"1970","journal-title":"J. Nerv. Ment. Dis"},{"key":"10.1016\/j.psychres.2025.116622_bib0003","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/09540261.2022.2040450","article-title":"Analysis of global prevalence of mental and substance use disorders within countries: focus on sociodemographic characteristics and income levels","volume":"34","author":"Castaldelli-Maia","year":"2022","journal-title":"Int. Rev. Psychiatr"},{"key":"10.1016\/j.psychres.2025.116622_bib0005","doi-asserted-by":"crossref","DOI":"10.47626\/1516-4446-2021-2359","article-title":"Ibogaine microdosing in a patient with bipolar depression: a case report","author":"Fernandes-Nascimento","year":"2022","journal-title":"Braz. J. Psychiatr"},{"key":"10.1016\/j.psychres.2025.116622_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2019.00943","article-title":"Therapeutic use of LSD in psychiatry: a systematic review of randomized-controlled clinical trials","volume":"10","author":"Fuentes","year":"2020","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.psychres.2025.116622_bib0006","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00213-020-05719-1","article-title":"Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants","volume":"238","author":"Galv\u00e3o-Coelho","year":"2021","journal-title":"Psychopharmacol. (Berl)"},{"key":"10.1016\/j.psychres.2025.116622_bib0007","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/NMD.0000000000000113","article-title":"Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases","volume":"202","author":"Gasser","year":"2014","journal-title":"J. Nerv. Ment. Dis"},{"key":"10.1016\/j.psychres.2025.116622_bib0008","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","article-title":"Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"9","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.psychres.2025.116622_bib0009","unstructured":"Global Burden of disease (GBD), 2019. Global health data exchange [WWW Document]. URL https:\/\/vizhub.healthdata.org\/gbd-results\/ (accessed 4.7.23)."},{"key":"10.1016\/j.psychres.2025.116622_bib0010","first-page":"1","article-title":"The psychedelic renaissance in clinical research: a bibliometric analysis of three decades of Human studies with classical psychedelics","author":"Hadar","year":"2022","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.psychres.2025.116622_bib0012","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3102\/10769986006002107","article-title":"Distribution theory for Glass\u2019s estimator of effect size and related estimators","volume":"6","author":"Hedges","year":"1981","journal-title":"J. Educ. Stat."},{"key":"10.1016\/j.psychres.2025.116622_bib0013","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/02791072.1979.10472092","article-title":"How LSD originated","volume":"11","author":"Hofmann","year":"1979","journal-title":"J. Psychedelic. Drugs"},{"key":"10.1016\/j.psychres.2025.116622_bib0014","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1176\/ajp.125.10.1352","article-title":"A controlled comparison of lysergic acid diethylamide (LSD) and dextroamphetamine in alcoholics","volume":"125","author":"Hollister","year":"1969","journal-title":"Am. J. Psychiatr"},{"key":"10.1016\/j.psychres.2025.116622_bib0015","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.biopsych.2022.08.025","article-title":"Lysergic acid diethylamide\u2013Assisted therapy in patients with anxiety with and without a life-threatening illness: a randomized, double-blind, placebo-controlled phase II study","volume":"93","author":"Holze","year":"2023","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116622_bib0016","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1177\/0269881112439253","article-title":"Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials","volume":"26","author":"Krebs","year":"2012","journal-title":"J. Psychopharmacol"},{"key":"10.1016\/j.psychres.2025.116622_bib0017","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1055\/s-0028-1094301","article-title":"LSD in the treatment of alcoholics *","volume":"4","author":"Kurland","year":"1971","journal-title":"PharmacoPsychiatry"},{"key":"10.1016\/j.psychres.2025.116622_bib0018","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/02791072.1972.10471465","article-title":"Psychedelic (LSD) therapy of neurotic disorders: short-term effects","volume":"5","author":"Lee McCabe","year":"1972","journal-title":"J. Psychedelic. Drugs"},{"key":"10.1016\/j.psychres.2025.116622_bib0019","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1176\/ajp.126.1.59","article-title":"A clinical study of LSD treatment in alcoholism","volume":"126","author":"Ludwig","year":"1969","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116622_bib0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/jebm.12372","article-title":"Risk of bias assessments and reporting quality of systematic reviews and randomized controlled trials examining acupuncture for depression: an overview and meta-epidemiology study","volume":"13","author":"Luo","year":"2020","journal-title":"J. Evid. Based. Med"},{"key":"10.1016\/j.psychres.2025.116622_bib0021","doi-asserted-by":"crossref","unstructured":"Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Group, T.P., 2009. Preferred reporting items for systematic reviews and meta-analyses : the PRISMA Statement 6. https:\/\/doi.org\/10.1371\/journal.pmed.1000097.","DOI":"10.1371\/journal.pmed.1000097"},{"key":"10.1016\/j.psychres.2025.116622_bib0022","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/s41386-023-01772-4","article-title":"Greater subjective effects of a low dose of LSD in participants with depressed mood","volume":"49","author":"Molla","year":"2024","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2025.116622_bib0023","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1001\/jama.1970.03170240060010","article-title":"The experimental use of psychedelic (LSD) psychotherapy","volume":"212","author":"Pahnke","year":"1970","journal-title":"JAMA: J. Am. Med. Assoc."},{"key":"10.1016\/j.psychres.2025.116622_bib0024","unstructured":"R Core Team, 2024. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. [WWW Document]. URL https:\/\/www.r-project.org\/."},{"key":"10.1016\/j.psychres.2025.116622_bib0025","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1001\/archpsyc.1973.01750360040005","article-title":"Residential psychedelic (LSD) therapy for the narcotic addict","volume":"28","author":"Savage","year":"1973","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116622_bib0026","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1177\/0269881114552713","article-title":"Treating drug dependence with the aid of ibogaine: a retrospective study","volume":"28","author":"Schenberg","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2025.116622_bib37","unstructured":"Sch\u00fcmemann, H., Bro\u017cek, J., Guyatt, G., Oxman, A. (2013). GRADE Handbook. Grading of Recommendations Assessment, Development and Evaluation (GRADE) Working Group. Available at: https:\/\/gdt.gradepro.org\/app\/handbook\/handbook.html."},{"key":"10.1016\/j.psychres.2025.116622_bib0029","doi-asserted-by":"crossref","first-page":"469","DOI":"10.15288\/qjsa.1966.27.469","article-title":"A controlled study of lysergide in the treatment of alcoholism. I . The effects on drinking behavior","volume":"27","author":"Smart","year":"1966","journal-title":"Q. J. Stud. Alcohol"},{"key":"10.1016\/j.psychres.2025.116622_bib0030","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1002\/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V","article-title":"Explaining heterogeneity in meta-analysis: a comparison of methods","volume":"18","author":"Thompson","year":"1999","journal-title":"Stat, Med"},{"key":"10.1016\/j.psychres.2025.116622_bib0031","doi-asserted-by":"crossref","first-page":"932","DOI":"10.15288\/qjsa.1970.31.932","article-title":"Lysergide treatment of schizophrenic and nonschizophrenic alcoholics; A controlled evaluation","volume":"31","author":"Tomsovic","year":"1970","journal-title":"Q. J. Stud. Alcohol"},{"key":"10.1016\/j.psychres.2025.116622_bib0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J. Stat, Softw"},{"key":"10.1016\/j.psychres.2025.116622_bib0033","article-title":"About mental disorders. World Health Organization","year":"2019","journal-title":"Reg. Off. East. Mediterr. [WWW Doc., URL"},{"key":"10.1016\/j.psychres.2025.116622_bib0034","unstructured":"World Health Organization (WHO), 2020. Depression (fact sheet) 2020 [WWW Document]. URL https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/depression (accessed 5.3.23)."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178125002707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178125002707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:44:08Z","timestamp":1778946248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178125002707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":34,"alternative-id":["S0165178125002707"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2025.116622","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of LSD in the treatment of mental and substance use disorders: A systematic review of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2025.116622","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116622"}}